Dr. Derek Kunimoto visits the AZTV studios to discuss CentraSight’s Implantable Telescope for people with end-stage macular degeneration (wet and dry). For more information, call 602-222-2221 or visit www.CentraSight.com. Age-related macular degeneration (AMD) is the most common cause of severe vision loss in patients over 65. This condition involves a breakdown of the macula, the central… Read More »
Dr. Pravin U. Dugel – Ocular Surgery News U.S. Edition, June 25, 2018 Unmet needs and new options There are unmet needs for DME, mainly related to the high rate of poor responders and the burden of frequent injections. “There are still patients that have suboptimal improvement, so better efficacy is still an unmet need.… Read More »
According to the American Academy of Ophthalmology, approximately 37 million adults in America have age-related macular degeneration, cataract, diabetic retinopathy, or glaucoma, all of which can cause visual impairment or blindness. However, recent studies show that making healthy choices and getting regular eye exams can help reduce a person’s risk of vision loss. In support… Read More »
Pravin U. Dugel, MD, discusses the HAWK and HARRIER studies, particularly with regard to whether the disease activity assessment done at week 16 can predict which patients can be extended to 12 weeks. He also explains why this is important from a clinical standpoint. Interview from the 2018 ARVO Annual Meeting where leading experts recap… Read More »
HONOLULU — The recent HAWK and HARRIER trials of Novartis’ brolucizumab for the treatment of neovascular age-related macular degeneration has helped researchers predict which patients will need an 8-week dosing regimen or a 12-week regimen with an almost 90% predictability rate, Pravin Dugel, MD, said at the Association for Research in Vision and Ophthalmology meeting… Read More »
The use of the anti-VEGF agent ranibizumab for the treatment of neovascular age-related macular degeneration (nAMD) in patients aged 85 and over does not increase a patient’s risk of systemic serious adverse events (SAEs) like heart attack or stroke. Although the study, led by Pravin Dugel, MD, a clinical professor with the University of Southern… Read More »
The staff at RCA are dedicated to providing the highest quality of medical care with the latest technology. The RCA family is composed of 9 physicians who are all ophthalmologists. All of our physicians are Board Certified by the American Board of Ophthalmology, with additional subspecialty training in the diagnosis and treatment of diseases affecting… Read More »
The ideal candidate will possess the following. Ophthalmology experience preferred, but willing to train the right candidate with Medical Assistant Experience. Medical Assistant must possess certification from an accredited program Must be able to work flexible hours and be able to travel via car or plane throughout the state. Photography (FA and OCT) experience helpful Must… Read More »
INNOVATION IN RETINA SURGERY: Technological innovation is crucial to the continued improvement
of vitreoretinal surgery. Leigh Spielberg Posted: EUROTIMES – Thursday, March 1, 2018 Technological innovation is crucial to the continued improvement of vitreoretinal surgery. This was abundantly apparent during the RetinaTech Bio-Engineering Session during the 17th EURETINA Congress in Barcelona, Spain. Subtitled “Where Surgery… Read More »
These novel strategies may change DME treatment paradigm By: Michelle Dalton, ELS; Reviewed by Pravin U. Dugel, MD There is no denying that the anti-vascular endothelial growth factor A (anti-VEGF-A) monotherapy has “absolutely revolutionized our treatment of diabetic macular edema (DME).” However, there is a subset of patients in whom the anti-VEGFs are not an… Read More »
